Long-Acting Injectable (LAI) Atypical Antipsychotics
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Illinois policy alerts
Know when Blue Cross Blue Shield - Illinois releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs prior authorization and utilization of preferred and non-preferred LAI atypical antipsychotics for adults with schizophrenia, schizoaffective disorder, or bipolar I disorder when consistent with the specific medication's FDA labeling. It applies to providers requesting coverage through Blue Cross Blue Shield of Illinois.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.